GC1123

· GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC1123, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ [Phase 1]

See pricing